Does VALBENAZINE Cause Product dose omission issue? 70 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Product dose omission issue have been filed in association with VALBENAZINE (INGREZZA). This represents 0.3% of all adverse event reports for VALBENAZINE.
70
Reports of Product dose omission issue with VALBENAZINE
0.3%
of all VALBENAZINE reports
3
Deaths
20
Hospitalizations
How Dangerous Is Product dose omission issue From VALBENAZINE?
Of the 70 reports, 3 (4.3%) resulted in death, 20 (28.6%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VALBENAZINE. However, 70 reports have been filed with the FAERS database.
What Other Side Effects Does VALBENAZINE Cause?
Drug ineffective (2,625)
Somnolence (2,339)
Fatigue (1,599)
Tremor (1,455)
Tardive dyskinesia (1,383)
Fall (1,056)
Dizziness (887)
Death (879)
Therapeutic product effect decreased (823)
Drooling (821)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which VALBENAZINE Alternatives Have Lower Product dose omission issue Risk?
VALBENAZINE vs VALBENAZINE DITOSYLATE
VALBENAZINE vs VALDECOXIB
VALBENAZINE vs VALERIAN
VALBENAZINE vs VALGANCICLOVIR
VALBENAZINE vs VALIUM